Ketones: the double-edged sword of SGLT2 inhibitors?
Beatrice Lupsa, Richard G. Kibbey, Silvio E. Inzucchi
Topics & Concepts
Ketone bodiesRenal glucose reabsorptionMedicineDiabetes mellitusDiabetic ketoacidosisDrug classBlood pressureType 2 diabetesKetoacidosisEmpagliflozinReabsorptionPharmacologyKidneyDrugEndocrinologyType 1 diabetesMetabolismDiabetes Treatment and ManagementPancreatic function and diabetesMetabolism, Diabetes, and Cancer